Tagged Articles

ovarian cancer 206 articles

Will FDA budget cuts affect talc-ovarian cancer research?

In the recent talc-ovarian cancer trials, one of Johnson and Johnson’s primary defenses has been to cite that a number of health and safety regulatory agencies have not labeled talc as a carcinogen. As we have reported previously on Righting Injustice, in court J&J’s lawyers claim that these “watchdogs” have already “intensively analyzed whether talc causes cancer” and stand firmly on the side of the safety of talc, but this is misleading. One of the regulatory agencies always included in Johnson and Johnson’s list is the U.S. Food and Drug Administration (FDA), which in fact last year awarded an Office of ... Read More

Valeant holds J&J responsible for talc troubles

Johnson and Johnson has been facing very public lawsuits over the last year and a half, with allegations that its talc-containing products cause ovarian cancer. Thus far, four juries have convicted the company of failure to warn consumers of this cancer risk and held it accountable for plaintiffs’ injuries, with massive verdicts of $110 million, $72 million, $70 million and $55 million. Two of those juries also held J&J’s talc provider Imerys Talc America responsible and ordered it to pay damages as well. The two main products being disputed are Johnson’s Baby Powder and Shower to Shower body powder. In ... Read More

Talc-ovarian cancer trials spark tort reform debate

In a recent article about the talc-ovarian cancer trials that have taken place in St. Louis Circuit Court over the last year and half, the St. Louis Post-Dispatch addresses some of the criticism that has come against the litigation that has brought so much publicity to their city. The large verdicts last year against Johnson and Johnson of $72 million, $55 million and $70 million drew the attention of the American Tort Reform Association, which placed St. Louis Circuit Court at the top of its annual ranking of “judicial hellholes.” In May, a St. Louis jury awarded the largest verdict ... Read More

Next St. Louis talc-ovarian cancer trial to start in June

It’s been just over two weeks since the conclusion of the last trial in St. Louis against Johnson and Johnson over the ovarian cancer risk connected to its talc-containing products. In that trial the Missouri jury found the company and its talc provider, Imerys, to be responsible for the development of plaintiff Lois Slemp’s ovarian tumors. She had used Johnson and Johnson products such as Johnson’s Baby Powder and Shower to Shower for feminine hygiene for four decades prior to being diagnosed with cancer in 2012. Slemp’s was the fifth bellwether trial to be held in the state, where thousands ... Read More

Studies suggest cranberries could help women with ovarian cancer

Ovarian cancer is the most deadly cancer of the female reproductive system and the fifth leading cause of cancer-related death among women. According to the Ovarian Cancer Research Fund Alliance the survival rate is much lower than that of other cancers affecting women; the relative five-year survival rate is 46.246 percent. This deadly cancer has been in the news recently with high-profile lawsuits against Johnson and Johnson accusing the health-care company of knowingly marketing products that increase ovarian cancer risk. Johnson and Johnson has lost four of the five lawsuits that have gone before St. Louis juries in the last ... Read More

Should women stop using Baby Powder because of cancer risk?

In light of a fourth St. Louis jury verdict finding Johnson and Johnson’s talc products to blame for the development of a woman’s ovarian cancer, Tech Times asks if women should stop using baby powder. The website acknowledges the juries’ recent decisions in favor of the plaintiffs who claimed that their decades of using talc products such as Johnson’s Baby Powder and Shower to Shower caused their ovarian cancer. In fact these juries not only validated these women’s claims, they also chose to impugn heavy penalties on Johnson and Johnson and talc provider Imerys Talc America, with verdicts totaling $307 ... Read More

$110 million verdict links talc to ovarian cancer; Fourth plaintiff win

Johnson and Johnson has been hit with its biggest talc verdict yet. Yesterday, after 10 hours of deliberations, a St. Louis jury awarded more than $110 million to plaintiff Lois Slemp, who alleged her four decades of daily use of the company’s talc-containing products were responsible for the development of her ovarian tumors. Law360 reports that the jury found in favor of plaintiff Lois Slemp on all of her claims, which included conspiracy, breach of implied warranty and negligence. The defendants, Johnson and Johnson, its Johnson & Johnson Consumer Inc. unit and its talc supplier, co-defendant Imerys Talc America Inc., ... Read More

Lawyer urges jury to hold J&J accountable in talc trial

The jury has been deliberating since yesterday over evidence presented in the fifth St. Louis talc trial. Plaintiff Lois Slemp blames her four decades of daily use of Johnson and Johnson’s talc-containing products for the development of her ovarian tumors, diagnosed in 2012. She is one of thousands of women who have brought suits against the pharmaceutical giant for not warning them of the decades of studies linking talc to increased risk for ovarian cancer. Law360 reports that in closing arguments Slemp’s attorney Allen Smith of The Smith Law Firm said, “These defendants instead of just letting the science dictate ... Read More

Out-of-state claims argument quashed in mesh, talc litigation

In response to the U.S. Supreme Court’s decision in January to take up two jurisdiction related appeals, Boston Scientific Corp. and Johnson and Johnson unit Ethicon Inc. both filed motions arguing that the results of these pending appeals could force out-of-state plaintiffs out of the Philadelphia County pelvic mesh mass tort program. This consolidated litigation has been handling allegations of injuries caused by defective pelvic mesh products since February 2014, and Ethicon has had to pay damages of $26 million after losing two trials. Ethicon hoped to stay 106 cases by out-of-state plaintiffs, mentioned in its motion, and BSC, six. ... Read More

Woman with ovarian cancer testifies against J&J in fifth talc trial

Lois Slemp, the fifth plaintiff to go to trial in the past two years alleging Johnson and Johnson’s talc products caused her ovarian cancer, was too sick to testify in court last week. Ms. Slemp is one of thousands of women who are suing J&J and its talc supplier, Imerys Talc America, alleging the companies knew of the link between ovarian cancer and talc use for feminine hygiene but failed to warn women. The St. Louis jury saw audio testimony from Ms. Slemp that was recorded during her deposition in July 2016. Law360 reports that she said she saw ads for ... Read More